Real‐world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancer

Documenti analoghi

• Prognostic factors and benefit populations of ovarian function suppression in premenopausal HR+/HER2+ early‐stage breast cancer patients who received trastuzumab: Evidence from a real‐world study with long‐term follow‐up
  di: Jie Ju, et al.
  Pubblicazione: (2024)
• Impact of HER2‐low expression on the efficacy of endocrine therapy with or without CDK4/6 inhibitor in HR‐positive/HER2‐negative metastatic breast cancer: A prospective study
  di: Yun Wu, et al.
  Pubblicazione: (2024)
• Menopausal hormone therapy after ovarian cancer: A 10‐year survival analysis in premenopausal women
  di: Åsa Ehlin von Kartaschew, et al.
  Pubblicazione: (2026)
• Squid processing machine
  di: Berk, Z., et al.
  Pubblicazione: (1974)
• Automated Long‐Short‐Term Echo State Self‐Attention Network Model for Clone Node Attack Detection in Edge‐Assisted Wireless Sensor Networks
  di: S. Bhuvana
  Pubblicazione: (2026)